Free Newsletter
Pharma CEOs pitch their own reform ideas
If drug company CEOs had their way, U.S. healthcare reform would look quite different from the package now making its way through the Senate. At a Cleveland Clinic summit this week, drugmaker execs offered their own prescriptions for the healthcare system. Here's a sampling:
Schering-Plough chief Fred Hassan (photo) would tax sugar-sweetened sodas, as some lawmakers have suggested. He'd also require people who have unhealthy habits to pay more for their care. Presumably that would include smokers, heavy drinkers--maybe even those who imbibe too much sugary soda. "I feel if they're adding to the cost of the system, there has to be a level of responsibility," Hassan said (as quoted by Dow Jones).
AstraZeneca CEO David Brennan (photo) would cover gym memberships and other preventive measures, rather than restricting coverage to disease treatment. "Somehow we've got to get that flipped around so people take more responsibility," he said.
Daniel Vasella (photo), CEO of Novartis, took a different tack, recommending caps on medical-malpractice awards. Spending on malpractice insurance and defensive medicine is way out of hand, he says.
Like these pharma-sourced solutions? Should Congress tack them onto their current bills? Let us know what you think.
- read the Dow Jones piece
- get more from the Wall Street Journal Health Blog
Related Articles:
PhRMA deal draws Senate fire
Pharma serves as scapegoat for healthcare woes
Pharma's new aims explain reform support
Who said what in PhRMA's $80B deal?
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline


SHARE
WITH: